RECRUITING

Opiophobia in Adults With Advanced Cancer

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To explore the barriers and fears related to use of opioids among a population of adult outpatients with advanced cancer who continue to experience pain after receiving a prescription for opioid analgesia and hypothesized associations among opiophobia, anxiety, depression, pain intensity, pain interference, and opioid medication adherence.

Official Title

Opiophobia in Adults With Advanced Cancer

Quick Facts

Study Start:2025-08-01
Study Completion:2031-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07093567

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult patients with advanced cancer (defined as cancer that is unlikely to be cured and is locally advanced or distantly metastasized
  2. 2. Pain is the documented reason for the Supportive Care consultation
  3. 3. Have a prescription for an opioid analgesic
  4. 4. Able to read, speak, and consent in English.
  1. 1. Age less than 18 years
  2. 2. Do not have a prescription for an opioid analgesic
  3. 3. Individuals for whom there is documentation of inability to provide consent in the medical record
  4. 4. Women who are pregnant
  5. 5. Patients with a substance use disorder (including alcohol use disorder and excluding tobacco use disorder) documented in the electronic health record under History of Present Illness or in the Medical History.

Contacts and Locations

Study Contact

Eileen Hacker, PHD,RN
CONTACT
(713) 563-4004
ehacker@mdanderson.org

Principal Investigator

Eileen Hacker, PHD, RN
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Eileen Hacker, PHD, RN, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-01
Study Completion Date2031-01-01

Study Record Updates

Study Start Date2025-08-01
Study Completion Date2031-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer